D.E. Shaw & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,500
| Closed | -$2.71M | – | 4668 |
|
|
2020
Q4 | $2.71M | Hold |
23,500
| – | – | ﹤0.01% | 2351 |
|
|
2020
Q3 | $2.29M | Hold |
23,500
| – | – | ﹤0.01% | 2309 |
|
|
2020
Q2 | $2.88M | Hold |
23,500
| – | – | ﹤0.01% | 2111 |
|
|
2020
Q1 | $2.06M | Sell |
23,500
-15,000
| -39% | -$1.59M | ﹤0.01% | 2143 |
|
|
2019
Q4 | $4.03M | Buy |
38,500
+3,600
| +10% | +$404K | ﹤0.01% | 1905 |
|
|
2019
Q3 | $4.01M | Hold |
34,900
| – | – | ﹤0.01% | 1819 |
|
|
2019
Q2 | $6.02M | Hold |
34,900
| – | – | 0.01% | 1468 |
|
|
2019
Q1 | $5.88M | Sell |
34,900
-10,100
| -22% | -$1.5M | 0.01% | 1443 |
|
|
2018
Q4 | $4.38M | Hold |
45,000
| – | – | 0.01% | 1595 |
|
|
2018
Q3 | $7.77M | Buy |
45,000
+10,000
| +29% | +$1.44M | 0.01% | 1266 |
|
|
2018
Q2 | $4.88M | Buy |
35,000
+15,000
| +75% | +$2.13M | 0.01% | 1554 |
|
|
2018
Q1 | $2.25M | Sell |
20,000
-66,200
| -77% | -$8.32M | ﹤0.01% | 1967 |
|
|
2017
Q4 | $11.4M | Hold |
86,200
| – | – | 0.02% | 957 |
|
|
2017
Q3 | $8.75M | Hold |
86,200
| – | – | 0.01% | 1027 |
|
|
2017
Q2 | $8.64M | Hold |
86,200
| – | – | 0.01% | 984 |
|
|
2017
Q1 | $10.4M | Sell |
86,200
-47,700
| -36% | -$5.85M | 0.02% | 863 |
|
|
2016
Q4 | $15M | Buy |
133,900
+40,000
| +43% | +$4.81M | 0.03% | 746 |
|
|
2016
Q3 | $12.5M | Buy |
93,900
+26,200
| +39% | +$2.5M | 0.02% | 778 |
|
|
2016
Q2 | $6.2M | Buy |
67,700
+20,000
| +42% | +$1.68M | 0.01% | 1153 |
|
|
2016
Q1 | $3.44M | Hold |
47,700
| – | – | 0.01% | 1526 |
|
|
2015
Q4 | $3.31M | Buy |
47,700
+23,900
| +100% | +$1.95M | ﹤0.01% | 1739 |
|
|
2015
Q3 | $2.17M | Sell |
23,800
-2,300
| -9% | -$256K | ﹤0.01% | 2039 |
|
|
2015
Q2 | $3.21M | Buy |
26,100
+13,800
| +112% | +$1.57M | ﹤0.01% | 1821 |
|
|
2015
Q1 | $1.12M | Buy |
+12,300
| New | +$999K | ﹤0.01% | 2481 |
|
|
2014
Q3 | – | Sell |
-10,000
| Closed | -$1.07M | – | 4492 |
|
|
2014
Q2 | $1.07M | Buy |
+10,000
| New | +$695K | ﹤0.01% | 2878 |
|
Other funds holding GWPH
D.E. Shaw & Co's GWPH Position: Q2 2021 in Review
D.E. Shaw & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 259,796 shares — an estimated $56.4M sold.
D.E. Shaw & Co first reported a position in GWPH in Q2 2014 and held it in 21 quarters. The position peaked at $56.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- D.E. Shaw & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- D.E. Shaw & Co sold 259,796 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $56.4M.
- D.E. Shaw & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 21 quarters.
- D.E. Shaw & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $56.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.